Prosthetics firm in growth mode
Sales of i-limb give Touch Bionics a helping hand
Artificial limb producer Touch Bionics has benefited from growth in its European markets, notably in France where the i-limb is now officially approved and funded by the French governmental health authorities.
Revenue at the Livingston-based company grew 11% last year to £15 million.
Ian Stevens, chief executive, said: “We are pleased with our 2015 performance and are proud that there have now been more than 5,000 i-limb wearers fitted world-wide.
“We introduced the i-limb quantum and i-digits quantum hands, both of which can be controlled using simple gestures and are stronger and faster than their predecessors. We anticipate continued growth from sales of these electronic prosthetic hands and partial hands in 2016.”
Touch Bionics was the first company to develop an electrically powered prosthetic hand with five independently powered fingers and the company continues to be a pioneer in upper limb prosthetics.
The company’s products include electronic prosthetic hand and prosthetic fingers, as well as passive silicone prostheses that closely match the natural appearance of the wearer.
A spin-out from the UK’s National Health Service, Touch Bionics was founded by inventor David Gow and is funded and supported by Archangel Investors and Scottish Enterprise.